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Background:Haemolytic infection lyses red blood cells, releasing haemoglobin (Hb) into the plasma. Although re-
cent studies showed that immune cells recognize redox-active cytotoxic extracellular Hb (metHb) bound to
pathogen-associatedmolecular patterns (PAMPs), currently available information is limited to experiments per-
formed in deﬁned conditions using single cell lines. Therefore, a systemic approach targeting primary whole
blood cells is required to better understand the cellular immune defence against metHb and PAMPs, when
under a haemolytic infection.
Methods: We investigated how human white blood cells, including neutrophils, respond to metHb and
lipoteichoic acid (LTA) by measuring reactive oxygen species (ROS), signalling mediators (ERK and p38), NF-
κB, cytokines, elastase secretion and cell activation markers.
Findings:metHb activates NF-κB in TLR2-expressing HEK293 cells but not in normal or TLR9-expressing HEK293
cells. Treatment of isolated neutrophils with metHb increased production of ROS and expressions of IL-8, TNFα,
and CD11b, which were further enhanced by metHb + LTA complex. While LTA stimulated the survival of neu-
trophils, it caused apoptotic cell death when complexed with metHb. The activation of neutrophils by
metHb + LTA was subdued by the presence of other types of white blood cells.
Interpretation:metHb andmetHb+ LTA complex are ligands of TLR2, inducing an unconventional TLR signalling
pathway. Neutrophils are a highly sensitive cell type to metHb + LTA complex. During a haemolytic infection,
white blood cells in the vicinity crosstalk to modulate neutrophil TLR-signalling induced by metHb and LTA.cience
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. This i© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Extracellular haemoglobin (Hb) is readily oxidized into metHb,
which is highly redox-active and cytotoxic due to its pseudoperoxidase
activity (metHb-POX) (Jiang et al., 2007). Dangerous levels of cell-free
metHb may persist in the plasma, for example in sickle cell anaemia
(1.6 mg/ml) and paroxysmal nocturnal hemoglobinuria (5–20 mg/ml)
(Schaer et al., 2013; Hartmann et al., 1966). The plasma metHb as well
as pathogen-associated molecular patterns (PAMPs) are released into
the plasma in an infection by haemolytic microbes, which may cause
systemic inﬂammatory responses leading to multiple organ dysfunc-
tions. metHb is normally rapidly scavenged by haptoglobin, scavenger
receptor class (SR)-B1, and CD163. The internalized metHb undergoes
detoxiﬁcation and degradation (Subramanian et al., 2013; Schaer and
Alayash, 2010). However, in severe haemolysis, massive levels of
metHb overwhelm the capacity ofmetHb scavengers leading to excessive
production of reactive oxygen species (ROS) by metHb-POX, which
perturbs immune homeostasis (Olsson et al., 2012). metHb may bind tos, National University of
s an open access article underother damage-associated molecular patterns (DAMPs) and PAMPs,
which are recognized by pattern recognition receptors such as TLRs in
various immune cells, to trigger pro-inﬂammatory responses.When pres-
ent in the plasma, metHb is a highly redox-reactive major DAMP that
threatens the integrity of the white blood cells (WBCs), but its potentials
to signal through TLRs are hitherto unclear (Lee and Ding, 2013). The
methicillin-resistant strain of Staphylococcus aureus is a notorious
haemolytic Gram-positive bacterium, which has become a major public
health problem (Iwamoto et al., 2013; Stryjewski and Corey, 2014).
Lipoteichoic acid (LTA) is the key immunostimulatory component of
S. aureus that triggers TLR2-activating innate immune system of the
host. Hb has been known to form a complex with S. aureus LTA to poten-
tiate the immune stimulatory effect of LTA (Hasty et al., 2006). We
previously reported the mechanism of ROS production by metHb-POX,
showing that binding of LTA to metHb enhances the production of ROS,
which not only kills the invading microbe, but is also harmful to the
host blood cells (Jiang et al., 2007; Bahl et al., 2011; Du et al., 2010).
Neutrophils are one of the ﬁrst responding immune cells to an
infection. Themigration of neutrophils into the site of infection–inﬂam-
mation is mediated by PAMPs from microbes or DAMPs derived
from disrupted host cells. At the site of infection, neutrophils rapidly
combat pathogens by unleashing ROS and proteases. Furthermore,the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. metHb-POX activity in the presence of LTA. (a) Kinetics of O2•− production
induced by different amounts of metHb. (b) Increase or inhibition of POX activity of
metHb (4 μg/ml) by LTA and ODN2395.
226 S.-K. Lee et al. / EBioMedicine 2 (2015) 225–233antimicrobial proteins stored in their cytoplasmic granules are released
(Nathan, 2006). The azurophil granules contain myeloperoxidase,
defensins, cathepsin G, and elastase, which are released upon activation
and degranulation of the neutrophils. Amongst these, elastasewhich is a
major serine protease is involved in various inﬂammatory responses
(Pham, 2006). Neutrophils are known to interact with other leukocytes
through cell–cell contact, and they secrete cytokines and chemokines.
They modulate dendritic cell maturation and trafﬁcking and are able
to cross-present antigens to memory CD4+ T cells as well as to naïve
CD8+ T cells, which subsequently amplify CD8+ T cell response to the
antigen (Beauvillain et al., 2007). Direct interaction between neutro-
phils and T cells has been shown in the regression of cancer as well as
infectious diseases (Stoppacciaro et al., 1993;Ma et al., 2009). ROS, pro-
duced by activated neutrophils, inhibits the effector functions of NK
cells, while cytokines such asGM-CSF and IFN-γ released from activated
NK cells, prolong the survival of neutrophils in an in vitro system
(Costantini and Cassatella, 2011). Moreover, depletion of neutrophils
impairs the recruitment of monocytes and lymphocytes to the inﬂam-
matory site. On the other hand, the immune suppressive capacity of
neutrophils in T cell proliferation during acute systemic inﬂammation
has also been reported (Pillay et al., 2012).
Considering the diverse functions of neutrophils in inﬂammation,
we envisaged that neutrophils would play a signiﬁcant role in response
to plasma metHb during a haemolytic condition. Therefore, we investi-
gated the response of neutrophils and the other types of blood cells, to
metHb and LTA. Here, we show that metHb is an endogenous DAMP li-
gand for TLR2, and that neutrophils are one of the most sensitive cell
types responding to (metHb + LTA)-induced production of ROS. Inter-
estingly, this effect is diminished by the presence of other leukocytes,
indicating that the white blood cells communicate with each other to
modulate cellular response during a haemolytic infection.
2. Materials and Methods
All procedures followed the guidelines of the National University of
Singapore Institutional Review Board (NUS-IRB Ref. code: B-14-063E).
Buffy coats were obtained from the Blood Bank with appropriate in-
formed consents from the volunteers.
2.1. Cells and Reagents
HEK293 clones expressing human TLR2, TLR9 and S. aureus LTA
(LTA-SA) were purchased from InvivoGen (San Diego, California,
USA). Human Hb, blasticidin, and hygromycin were from Sigma-
Aldrich (St. Louis, MO, USA). Buffy coat fromhealthy donorswas obtain-
ed from the Blood Bank, National University Hospital, Singapore. Prima-
ry blood cells were incubated in 5% CO2 at 37 °C inHEPES-buffered RPMI
1640 containing 100 U/ml penicillin, 100 μg/ml streptomycin, and 2%
FBS. HEK293 cells were cultured in DMEM supplemented with 10%
FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin. Adult human
Hb, which contains 96.5–98.5% HbA1 (α2β2 dimer) and 1.5–3.5%
HbA2 (α2δ2 dimer), has been veriﬁed to be in the metHb state
by spectrophotometric scanning between 500 and 700 nm (Du et al.,
2010). As the endotoxin concentration in Hb was determined to be
2.86 EU/mg/ml by PyroGene Recombinant Factor C kit (Lonza Inc.),
1 mg/ml of Hb was pre-treated with 5 μg/ml of polymyxin B, which
can scavenge 10 EU/ml of endotoxin. The metHb + LTA complex was
pre-formed by co-incubating 1 mg/ml metHb with 10 μg/ml LTA for
30 min.
2.2. Isolation of Human Neutrophils and Cellular Assays
Buffy coats obtained fromhealthy donorswere used for the isolation
and enrichment of neutrophils with HetaSept™ (Stem Cell Technologies
Inc.) according to the manufacturer's instructions. Immediately after
isolation, the cells were incubated with different concentrations ofmetHb, LTA or metHb + LTA for 1 h (or as described in the ﬁgure leg-
ends), in RPMI medium followed by washing with PBS. For TLR2
blocking assay, 3.8 × 105 neutrophils/well in 12-well plate were prein-
cubated with TLR2 blocking antibody (20 μg/ml, eBioscience) for 1 h
and then treated with metHb + LTA complex prepared as described
above. For the assessment of intracellular ROS production, the cells
were incubatedwith1 μMCM-H2DCFDA for 30min at 37 °C. Afterwash-
ing with PBS, the ﬂuorescence signal of CM-H2DCFDA in the cells was
measured by ﬂow cytometry (CyAn ADP ﬂow cytometer, Dako).
2.3. Isolation of Human Leukocytes and Stimulation
Human total leukocytes (referred as white blood cells, WBCs) were
isolated from buffy coat using HetaSep™ followed by EasySep™
Human Positive Glycophorin A Depletion Cocktail (Stem Cell Technolo-
gies Inc.), according to the manufacturer's instructions. Human PBMCs
were isolated from buffy coat by Ficoll-Paque density gradient centrifu-
gation. The cells were incubated with metHb, LTA or metHb + LTA
(as described above for neutrophils). Activated cells were assessed by
ﬂow cytometry for increased expression of activation markers, such as
CD86, CD69, CD11b, LFA-1, DNAM-1, and Icam-1. ROS production in-
duced in PBMCs or WBC treated with different stimulators was deter-
mined using CM-H2DCFDA as described above.
2.4. Chemiluminescence Assay forHaemoglobin Pseudoperoxidase (metHb-
POX) Activity
The effect of PAMPs on the metHb-POX activity was assessed by
measuring O2•−, using a chemiluminescence assay. O2•−-triggered
chemiluminescence of Cypridina luciferin analog (CLA) was measured
with a luminometer (Promega, Glomax 20/20), and expressed as
relative luminescence units per second (RLU/s). metHb incubated
with 25 μg/100 μl of each PAMP was added to a substrate mixture con-
taining 20 μM CLA and 5 mM H2O2 in 100 μl PBS (pH 7.4) and the
resulting chemiluminescence was immediately recorded in real-time
up to 150 s, according to Jiang et al. (2007).
2.5. NF-κB Reporter Assay
Stably transfected HEK293/hTLR2-HA, HEK293/hTLR9, and HEK293/
vector control cells were plated at the density of 2 × 105/well in 24-well
plates and transiently transfected for 24 h with NF-κB luc plasmid
227S.-K. Lee et al. / EBioMedicine 2 (2015) 225–233(Stratagene) or control plasmid (pRL-CMV, Promega) using Fermentas
TurboFect. Transfected cells were treated with various concentrations
ofmetHb, PAMPs ormetHb+PAMPs for 6 h before luciferase LARII sub-
strate (Promega) was added into the lysed cells. Stop & Glo reagent was
added for Renilla luciferase reading. Luciferase activity wasmeasured in
relative light units of ﬁreﬂy ﬂuorescence normalized against Renilla lu-
ciferase ﬂuorescence units. The results were presented as relative lucif-
erase activity against control treatment where the value from control
vector-transfected cells was taken as 100%.
2.6. Western Blot Analysis
HEK293/hTLR2-HA cells were challenged with metHb (0.5 mg/ml),
LTA (100 ng/ml) or metHb (0.5 mg/ml) + LTA (100 ng/ml) for 6 h.
For cell lines, LTA was applied at the optimized concentration of
100 ng/ml. The cell lysates were analyzed by immunoblotting using anti-
bodies against Phospho-p44/42 MAPK (Thr202/Tyr204), p44/42 MAPKFig. 2. TLR2-mediated signal transduction bymetHb, LTA andmetHb+LTA. (a)NF-κB activation
secretion from HEK293 cells expressing hTLR2-HA induced by metHb, LTA or metHb+ LTA com
metHb, LTA or metHb + LTA complex. Data are representative of at least 3 independent experi
P b 0.05 by two-tailed Student's t-test.(Erk1/2), Phospho-p38 MAPK (Thr180/Tyr182) and p38 MAPK (Cell
Signaling). Beta-actin was detected as a loading control.2.7. Flow Cytometry
Stimulated cellswere incubatedwith Fcγ receptor blocking antibody
for 20 min on ice and then stained for 30 min on ice with ﬂuorophore-
conjugated antibodies: CD56-APC, CD69-PEcy7, Icam-1-PE, CD86-Alexa
Fluor 488, CD11b-FITC, CD66b-APC and CD16-PE, from eBioscience and
LFA1-PECy5, CD14-APC/Cy7 and DNAM-1-FITC from Biolegend. After
washing thrice with PBS, the expression of surface molecules was mea-
sured by ﬂow cytometry (Beckman CyAn and BD BioScience Fortessa)
and data were analyzed with Flow Jo software and Summit software.
The mean ﬂuorescence intensity from speciﬁc antibodies was obtained
by subtracting the values from control isotype antibodies. Lymphocytes,
monocytes, and granulocytes, amongst theWBC population, were gatedbymetHb, LTA andmetHb+LTA inHEK293 cells expressing hTLR2-HA and TLR9. (b) IL-8
plex. (c) Phosphorylation of ERK and p38 in HEK293 cells expressing hTLR2 treated with
ments with similar results. §P b 0.05, dose dependency by regression analysis. * vs control,
228 S.-K. Lee et al. / EBioMedicine 2 (2015) 225–233based on side scatter and forward scatter, which were not affected by
stimulation (Supplementary Fig. 1).
2.8. Apoptosis Assay
Cell apoptosis and necrosis were determined using the annexin V-
FITC apoptosis detection kit and 7-AAD staining solutions (eBioscience)
according to the manufacturers' instructions. Brieﬂy, primary neutro-
phils andWBCs were separately stimulated for 10 h with different con-
centrations of metHb (0.25, 0.5, 1 mg/ml) or LTA (10 μg/ml, a
concentration optimized for primary cells) either singly or combined.
The cells were thenwashedwith PBS and binding buffer, and incubated
with FITC-conjugated annexin V and 7-AAD for 15min at room temper-
ature. After washing, the cell suspension was immediately analyzed on
an LSRFortessa.
2.9. Cytokine Determination
Cell culture supernatants obtained from 1 h-stimulated neutrophils,
WBC, and PBMC cultures were obtained by centrifugation at 500 ×g for
5 min and stored at−80 °C until tested. TNFα and IL-8 were measured
using OptEIA™ (BD Biosciences, USA) according to the manufacturer's
instructions. Secreted elastase was determined using PMN elastase
ELISA kit (eBioscience).
2.10. Statistical Analysis
Statistical signiﬁcances were analyzed using ANOVA, post-hoc
Bonferroni's test, regression analysis and 2-tailed Student's t-test.R2 R3
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3.1. Modulation of metHb-POX Activity by PAMPs
metHb increased POX activity dose-dependently within the concen-
tration range of 0–10 μg/100 μl as shown shortened reaction time
(Fig. 1a). To assess the direct effects of various PAMPs on the metHb-
POX activity, we incubated 4 μg/100 μl of metHb with 25 μg/100 μl of
LTA or CpG DNA (ODN2395) for 30 min, and then determined the gen-
eration of O2•− (ROS). LTA increased themetHb-POXactivitywhile ODN
decreased it (Fig. 1b). ODN2395 also reduced the metHb-POX activity
induced by LTA. These results suggest thatmetHb-POX activity is direct-
ly modulated by speciﬁc PAMPs.
3.2. metHb Triggers Immune Response via TLR2
Based on the above ﬁnding we hypothesized that certain TLR signal
transduction may be modulated by metHb + TLR ligand complexes,
exerting effects on the host innate immune response in haemolytic con-
ditions. To test this hypothesis, we ﬁrst assessed the effects ofmetHb on
TLR2 and TLR9,which are both activated by S. aureus (Parker and Prince,
2012). Recombinant HEK293 cells which stably express hTLR2 or hTLR9
were co-transfected with NF-κB (the common mediator of TLR signal-
ling) luciferase-expressing plasmid. The cells were treated 24 h later
withmetHb, LTA, ODN2395, or metHb+ LTA and then NF-κB activation
was measured by dual-luciferase reporter assay system. Interestingly,
not only LTA but also metHb alone dose-dependently activated NF-κB
in TLR2-expressing cells, while TLR9-expressing cells and control cells
did not respond tometHb (Fig. 2a). These results, obtained by luciferase
reporter assay, were further conﬁrmed by IL-8 production andA metHb+LTA 0
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229S.-K. Lee et al. / EBioMedicine 2 (2015) 225–233phosphorylation of ERK and p38 determined by ELISA and Western
blotting, respectively (Fig. 2b, c). Altogether, these results suggest that
metHb itself causes NF-κB activation through signals mediated by
TLR2, leading to induction of chemokines such as IL-8.
3.3. Neutrophils are Highly Sensitive to metHb + LTA Complex
To investigate the sensitivity of the different blood cell types to cell-
free Hb and LTA, we prepared neutrophils, PBMC, and whole WBC sep-
arately (Fig. 3a). Both metHb and LTA increased ROS production in iso-
lated neutrophils, which was further synergistically increased by
treatment with metHb+ LTA (Fig. 3b). Amongst the PBMC population,
metHb induced more ROS production in monocytes than in lympho-
cytes, but metHb+ LTA did not further inducemore ROS (Fig. 3c). Con-
sistently, we found that when WBCs were treated with metHb, the
neutrophils and monocytes within the WBC population produced in-
creased levels of ROS as compared to lymphocytes (Fig. 3d). However,
when the neutrophils were analyzed in the presence of other WBCs,
the metHb+ LTA complex did not synergistically increase ROS produc-
tion in neutrophils (Fig. 3d). IL-8 production from the isolated neutro-
phils was also further increased by metHb + LTA complex compared
to metHb or LTA alone, while its increase in PBMC or WBC induced by
metHb + LTA is not different from the level induced by metHb or LTA
alone (Fig. 3e). Compared to neutrophils, PBMC treated with metHb
produced much higher level of IL-8, while metHb + LTA complex did
not further increase IL-8 in PBMC. These results suggest that neutrophils
are highly sensitive to the imminent threat of metHb + LTA complex,
which prevails in a haemolytic infection, for example by S. aureus and
the stimulation of neutrophils by metHb + LTA is modulated by other
WBCs.
3.4. Activation of Neutrophils by metHb + LTA is Mediated by TLR2 and
Other Receptors
Human neutrophils have been shown to express all TLRs except
TLR3 (Hayashi et al., 2003). Although it is well-known that LTA speciﬁ-
cally targets TLR2, it is not certain whether during an S. aureus
haemolytic infection, the extracellular metHb (with/without LTA) spe-
ciﬁcally signals via TLR2. To determine whether metHb alone or
metHb + LTA complex induces immune signalling via TLR2, isolated
neutrophils were separately pretreated with TLR2-blocking antibody
or control isotype antibody. The synergistic increases of ROS, IL-8, and
TNFα in isolated neutrophils induced by metHb + LTA were markedly
decreased by treatment with TLR2-blocking antibody. Increases of
ROS in neutrophils by metHb alone were also decreased by TLR2-
blocking antibody, although the changes were not as signiﬁcant as
metHb + LTA treatment (Fig. 4). However, compared to mock control
(buffer treatment), the levels of ROS and TNFα produced by metHb
and metHb + LTA in the presence of TLR2-blocking antibody were sig-
niﬁcantly higher. This suggests that the metHb + LTA complex elicits
synergistic activation of neutrophils both through TLR2-dependent
and -independent pathways, indicating the potential involvement of
other receptors besides TLR2.
3.5. metHb Controls the Survival/Death of Leukocytes
To ascertain whether metHb and LTA affect neutrophil survival or
death, both isolated neutrophils and WBC were treated with metHb,
LTA or metHb + LTA complex and the apoptosis of the cells was
assessed by detecting Annexin V+/7AAD+ cells. metHb alone was
found to induce apoptosis in neutrophils regardless of the presence of
the other cell types (Fig. 5a, b). ThemetHb+ LTA complex signiﬁcantly
enhanced the apoptotic effect. However, LTA itself did not induce apo-
ptosis in either the neutrophils or the other leukocytes, but promoted
the survival of neutrophils. While monocytes underwent cell death
caused by metHb and metHb + LTA, the viability of the lymphocytesremained unaffected by these treatments (Fig. 5b). Taken together,
these results indicate that extracellular cytotoxic metHb elicits different
impacts on the death/survival of different leukocytes.3.6. Neutrophils Express Elastase and AdhesionMoleculesWhen Encounter-
ing metHb
Since elastase plays a major role in neutrophil extracellular trap for-
mation, transvascular migration, and apoptosis (Oltmanns et al., 2005),
we investigated the effects of metHb on elastase secretion from
neutrophils. ELISA showed that metHb dose-dependently induced
elastase secretion (Fig. 6a). Interestingly, treatment of neutrophils
withmetHb, LTA ormetHb+LTA also increased the expression of adhe-
sion molecules such as CD11b, LFA-1, and Icam-1 (Fig. 6b–d). The
metHb- or (metHb + LTA)-mediated production of elastase and adhe-
sion molecule in the neutrophils indicates that the migration of
neutrophils to the sites of inﬂammation could be facilitated by metHb
and LTA.
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Cells
As the inﬁltration of neutrophils into the infection–inﬂammation
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231S.-K. Lee et al. / EBioMedicine 2 (2015) 225–233TNFα by ELISA. We found that monocytes respond to both metHb and
LTA by up-regulating LFA-1, Icam-1, CD69, and CD86, although
they were not further increased by metHb + LTA (Fig. 7a). However,
LFA-1 marker in CD3+ T cells was increased by treatment with
metHb+LTA relative tometHb or LTA only (Fig. 7b). DNAM-1was con-
sistently expressed on NK cells (CD56+) regardless of the treatments
(Fig. 7c). Interestingly, TNFα expression in neutrophils was unchanged
by metHb. In contrast, there was a dose-dependent increase in TNFα
produced by the PBMCs (Fig. 7d).
On the premise that: (i) LFA-1 is required for T cell migration to tar-
get tissues as well as for optimal activation (Berlin-Rufenach et al.,
1999), and (ii) proliferation of T cells and IFN-γ production from T
cells are dependent on the expression of CD80 and CD86 in monocytes
(Subauste et al., 1998), our results imply that metHb ampliﬁes the0
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was buffer only treatment. (d) TNFα secretion frommetHb-stimulated neutrophils and PBMC,m
dose dependency by regression analysis.inﬂammatory response in WBCs by stimulating not only neutrophils
but also monocytes and T cells.
4. Discussion
One of the underlyingmechanisms of the cytotoxicity ofmetHb is its
ability to generate ROS and scavenge NO; the latter is known to play a
protective role in vascular homeostasis. Recent studies in our lab have
shown that the POX activity of metHb is triggered synergistically bymi-
crobial proteases and PAMPs such as LTA or LPS to produce ROS (O2•)
which was conﬁrmed in this study (Jiang et al., 2007). Binding of LTA
or LPS to metHb causes a conformational change of metHb which may
explain the increase in metHb-POX activity. But we found, in this
study that ODN2395 dramatically reduced the POX activity of metHb0.25 0.5 1
g/ml)
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Fig. 8. Schematic diagram ofWBC response tometHb+ LTA. Haemolytic bacterial infection e.g. by S. aureus, releases Fe3+metHb into the plasma, which is highly redox-active and inter-
acts with LTA. Neutrophils respond highly sensitively to metHb+ LTA complexes by activating unconventional TLR2-mediated signal transduction. Amongst the other leukocytes, mono-
cytes and T cells are activated by metHb, LTA and metHb + LTA by expressing adhesion and costimulatory molecules leading to modulation of neutrophil's responses. The detailed
molecular mechanism (denoted as “?” on dashed arrows) of TLR2 signal transduction induced by Hb + TLR ligand complex remains to be elucidated.
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activity appears to be due to the direct binding of ODN2395 to metHb,
which probably caused allosteric inhibition rather than a direct catalytic
site competition against LTA. These results suggest differential modula-
tion of the metHb-POX activity by different PAMPs during a haemolytic
infection.
By further investigations on the effects of interaction between
metHb and LTA on live human leukocytes, we discovered that metHb
is an endogenous ligand for TLR2 (Fig. 2a). As conﬁrmed in our experi-
ment, a typical TLR2 activation by LTA has been known to inhibit apo-
ptosis of neutrophils (Lotz et al., 2004). However, we observed metHb
to induce apoptosis of neutrophils, which was signiﬁcantly increased
bymetHb+LTA complex. As anticipated, blocking TLR2 in isolated neu-
trophils reduced the LTA-induced ROS production to basal level com-
pared to mock control (buffer treatment). Interestingly, higher levels
of ROS were produced by metHb and metHb + LTA compared to
mock control, even in the presence of TLR2 antibody. These results sug-
gest that there are other receptors on the neutrophils that may interact
with metHb and metHb+ LTA complex, besides TLR2. Since innate im-
mune responses are mediated multifariously, it is conceivable that
metHb-PAMPs modulate the functions of TLRs to stimulate distinct
signalling pathways in diverse immune cells, which warrants future in-
vestigation at the systemic level. Supporting this is our earlier demon-
stration of the co-operation of monocytes with endothelial cells in the
endocytosis of extracellular metHb4. Chronic haemolytic conditions,
which prevail in sickle cell anaemia, are accompanied by systemic endo-
thelial activation resulting in more adhesion of blood cells (Chen et al.,
2011).
Here, our ex vivo systemic analysis of the impact of extracellular Hb
and LTA on whole WBC populations demonstrates that neutrophils are
as sensitive as monocytes to metHb. Interestingly other leukocytes in
the whole blood system seemed to dampen the synergistic effect of
metHb + LTA on the neutrophils. For example, the presence of otherblood cell types suppressed further increase of ROS production induced
by metHb + LTA compared to metHb in neutrophils; otherwise the
metHb+ LTA caused synergistic increase in ROS production in isolated
neutrophils (Fig. 3b, d). Plausibly, the clearance of metHb by scavenging
receptors such as CD163 and (SR)-B1, which are known to be present
on macrophages and monocytes, partially relieves the impact of
metHb + LTA on the neutrophils. However, metHb- or (metHb +
LTA)-induced increase in the expressions of activation markers and cy-
tokines in the other leukocytes indicates that the other leukocytes are
more actively engaged in response to the effects of metHb on neutro-
phils. Particularly, the increase in cell adhesion molecules caused by
metHb, LTA or metHb + LTA, in various types of leukocytes suggests
that upon encountering metHb and LTA (e.g. in a Gram-positive
haemolytic infection), the neutrophils probably interact with other leu-
kocytes through cell–cell contact, and they secrete cytokines and
chemokines leading to the modulation of effector cell function at a
focal site of inﬂammation (Figs. 6, 7).
The regulation of neutrophil survival and death is critical to resolve
inﬂammation efﬁciently. TLR agonists and inﬂammatory cytokines
have been reported to delay apoptosis of neutrophils, which is associat-
edwith the expression of anti-apoptoticmolecules such as survivin pro-
tein and myeloid leukaemia cell differentiation protein (Francois et al.,
2005; Baumann et al., 2003; Altznauer et al., 2004). Furthermore, acti-
vated NK cells and T cells drive IFNγ and GM-CSF to prolong the
human neutrophil survival (Costantini et al., 2010; Pelletier et al.,
2010).We found that metHb does not increase TNFα production in iso-
lated neutrophils (Fig. 4), whereasmetHb+LTA does. However, metHb
induces TNFα in wholeWBC, resulting inmore severe apoptosis of neu-
trophils compared to the effect in isolated neutrophils (Fig. 5). It was re-
ported that low concentrations of TNFα enhance the survival of
neutrophils, but high concentrations induce apoptosis (Cross et al.,
2008). Our results suggest that apoptosis of neutrophils induced by
metHb and metHb + LTA, when in the presence of other leukocytes,
233S.-K. Lee et al. / EBioMedicine 2 (2015) 225–233may be caused by both: (i) TNFα produced from the other types of leu-
kocytes and (ii) ROS produced in the neutrophils.
Overall, our ﬁndings provide mechanistic insights on how metHb,
together with LTA, released during a systemic Gram-positive
haemolytic infection triggers neutrophil response and how the other
leukocytes might collaborate to orchestrate cellular defence as illustrat-
ed in Fig. 8. Future characterization of the proposed unconventional TLR
pathway could provide deeper understanding on how our blood system
circumvents the danger of the redox-active metHb, and PAMPs to re-
store homeostasis.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ebiom.2015.01.003.
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